Derma Sciences Story

Requested story not found. it has been either deleted or moved. View all stories for Derma Sciences.

Derma Sciences Latest Timeline

Derma Sciences is listed for 0.00. About 87.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.76. Some equities with similar Price to Book (P/B) outperform the market in the long run. Derma Sciences recorded a loss per share of 0.4. The entity had not issued any dividends in recent years. The firm had 1:8 split on the February 1, 2010.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Derma Sciences information on this page should be used as a complementary analysis to other Derma Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

If you are still planning to invest in Derma Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Derma Sciences' history and understand the potential risks before investing.